IDEC-C2B8 chimeric antibody targeted to the CD20 marker on B cells data

IDPH (San Diego) reported Phase II data in 34 patients infused with 375 mg/m2

Read the full 143 word article

How to gain access

Continue reading with a
two-week free trial.